StonvexLoading…
StonvexStonvexStonvexCore line items from NE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.29B | $3.06B | $2.59B | $1.41B |
Operating Income | $415.55M | $603.98M | $574.71M | $228.77M |
Net Income | $216.72M | $448.35M | $481.90M | $168.95M |
EPS (Diluted) | $1.35 | $2.96 | $3.32 | $1.73 |
Total Assets | $7.53B | $7.96B | $5.51B | $5.23B |
Total Liabilities | $2.98B | $3.31B | $1.59B | $1.63B |
Cash & Equivalents | $471.40M | $247.30M | $360.79M | $476.21M |
Free Cash Flow OCF − CapEx | $432.15M | $80.16M | $164.76M | $106.67M |
Shares Outstanding | 158.85M | 158.95M | 140.77M | 134.68M |